CD63-Mediated SARS-CoV-2 RBD Fusion Neoantigen DNA Vaccine Enhances Antitumor Immune Response in a Mouse Panc02 Model via EV-Targeted Delivery.
CD63介导的SARS-CoV-2 RBD融合新抗原DNA疫苗通过EV靶向递送增强小鼠Panc02模型中的抗肿瘤免疫反应。
期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines13090977
Liu Guang, Yuan Ziqing, Wu Ziyi, Yang Qiyv, Ding Tingbo, Yu Ker, Dong Jibin
CD6
SARS-CoV-2
CD63
肿瘤
肿瘤免疫
Mouse
免疫/内分泌
